Results 1 to 10 of about 13,261 (250)

Depression with chronic inflammatory demyelinating polyneuropathy [PDF]

open access: yesIndian Journal of Psychological Medicine, 2018
Depression and chronic inflammatory demyelinating polyneuropathy (CIDP) both are chronic illness of different etiopathology and are usually not looked for together while screening a patient. However, both have got a long incubation period as well as have
Arun Marwale   +4 more
doaj   +3 more sources

Chronic inflammatory demyelinating polyneuropathy. A case description [PDF]

open access: yesClinical Case Reports
Key Clinical Message Patients affected by chronic inflammatory demyelinating polyradiculoneuropathy require close follow up due to the neuronal demyelination along with axonal degeneration associated with the disease process, giving the opportunity to ...
Garcia‐Castillo María Ariana
doaj   +2 more sources

Atypical Chronic Inflammatory Demyelinating Polyneuropathy

open access: yesPediatric Neurology Briefs, 2010
Researchers at the Royal Children’s Hospital and Melbourne University, Victoria, Australia report a 12-year-old boy with a 12-month history of progressive weakness affecting extremities and neck flexion but no facial weakness.
J Gordon Millichap
doaj   +3 more sources

LONG-LASTING CRANIAL NERVE III PALSY AS A PRESENTING FEATURE OF CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY [PDF]

open access: gold, 2015
We describe a patient with chronic inflammatory demyelinating polyneuropathy (CIDP) in which an adduction deficit and ptosis in the left eye presented several years before the polyneuropathy.
LA BELLA, V., Spataro, R.
core   +5 more sources

How I Treat Chronic Inflammatory Demyelinating Polyneuropathy Podcast [PDF]

open access: yesNeurology and Therapy, 2023
Chronic inflammatory demyelinating polyneuropathy (CIDP) is an acquired immune-mediated neuropathy that typically presents with progressive or relapsing, symmetric, proximal, and distal weakness of upper and lower limbs, sensory involvement of at least ...
Urvi Desai
doaj   +2 more sources

Steroids for Chronic Inflammatory Demyelinating Polyneuropathy

open access: yesPediatric Neurology Briefs, 2005
The efficacy and safety of high-dose, intermittent IV methylprednisolone (IVMP) as initial and long-term maintenance therapy for chronic inflammatory demyelinating polyneuropathy (CIDP) were analyzed by a retrospective review of outcome data derived from
J Gordon Millichap
doaj   +3 more sources

Chronic Inflammatory Demyelinating Polyneuropathy Following Natural Influenza A Infection in a Pediatric Patient: A Case Report and Literature Review [PDF]

open access: yesCase Reports in Neurological Medicine
Chronic inflammatory demyelinating polyneuropathy (CIDP) following viral infections and influenza vaccination has been well documented. However, there have been no confirmed natural influenza A infections leading to development of CIDP.
Emily Grew   +2 more
doaj   +2 more sources

CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY IN CHILDREN: DIAGNOSIS AND TREATMENT

open access: diamondВопросы современной педиатрии, 2014
Chronic inflammatory demyelinating polyneuropathy (CIDP) in children is a rare autoimmune disease of the peripheral nervous system. The article analyzes current international diagnostic criteria and clinical presentation features of the disease in ...
А.L. Kurenkov   +3 more
doaj   +3 more sources

Tailoring of therapy for chronic inflammatory demyelinating polyneuropathy

open access: yesNeural Regeneration Research, 2015
Chronic inflammatory demyelinating polyneuropathy (CIDP) is a treatable immune-mediated disorder, which causes in its typical form, symmetric proximal and distal weakness with large fibre sensory impairment involving the four limbs. There are currently three main first-line therapeutic options for CIDP. These consist of corticosteroids, immunoglobulins
Yusuf A Rajabally
doaj   +4 more sources

Chronic inflammatory demyelinating polyneuropathy [PDF]

open access: yesNeurologic Clinics, 2013
Chronic inflammatory demyelinating polyneuropathy (CIDP) is characterized clinically by a progressive symmetrical weakness evolving over a period of at least 2 months. There is increased CSF protein and conduction block, reduced nerve conduction velocities, increased distal latencies, and/or absent F wave or prolonged F wave latency in two or more ...
Elie Hadad   +2 more
  +11 more sources

Home - About - Disclaimer - Privacy